Sequencing in the cGVHD Treatment Paradigm | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Sequencing in the cGVHD Treatment Paradigm | Targeted Oncology - I…
2 months ago
targetedonc.com
Case Presentation: A 72-Year-Old Woman With Metastatic Colorectal Cancer | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Case Presentation: A 72-Year-Old Woman With Metastatic Colorecta…
Oct 4, 2021
targetedonc.com
Case Presentation: A 57-Year-Old Woman With Ovarian Cancer | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Case Presentation: A 57-Year-Old Woman With Ovarian Cancer | Tar…
Sep 23, 2021
targetedonc.com
Drawing Comparisons for Relevant Therapies in Patients With DLBCL | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Drawing Comparisons for Relevant Therapies in Patients With DLBCL …
Dec 9, 2024
targetedonc.com
Understanding JZP898: A Breakthrough mRNA Therapy for Solid Tumors | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Understanding JZP898: A Breakthrough mRNA Therapy for …
Aug 16, 2024
targetedonc.com
Case Review: Newly Diagnosed Stage IV Hodgkin Lymphoma | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Case Review: Newly Diagnosed Stage IV Hodgkin Lymphoma | Tar…
Jan 10, 2019
targetedonc.com
Risk of Recurrence in Stage 3B CRC | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Risk of Recurrence in Stage 3B CRC | Targeted Oncology - Immunother…
Oct 7, 2016
targetedonc.com
Monitoring Mantle Cell Lymphoma: PET Scans and MRD | Targeted O…
Sep 13, 2017
targetedonc.com
Choosing Between Atezolizumab and Pembrolizumab in Lung Canc…
Jul 2, 2018
targetedonc.com
Trimodality Therapy Plus Atezolizumab Investigated for Bla…
May 5, 2022
targetedonc.com
HERIZON-GEA-01: Zanidatamab ± Tislelizumab vs Trastuzumab Che…
3 months ago
targetedonc.com
The Targeted Pulse: Endometrial Cancer Scores Multiple FDA Appr…
Jun 23, 2024
targetedonc.com
GIST: Treatment Considerations | Targeted Oncology - Immunothera…
Jun 22, 2020
targetedonc.com
Current Treatment Options for DLBCL Besides R-CHOP Chemoth…
Mar 16, 2020
targetedonc.com
AML: Toxicities With CPX-351 | Targeted Oncology - Immunothera…
Jul 9, 2018
targetedonc.com
Immunotherapy Advances in Small Cell Lung Cancer Treatment | Targ…
Mar 6, 2025
targetedonc.com
NCCN Guidelines for Castleman's Disease | Targeted Oncology - Im…
Oct 31, 2016
targetedonc.com
Targeting PIK3CA Mutations in Breast Cancer | Targeted Oncolog…
Aug 12, 2023
targetedonc.com
Multiple Myeloma Treatment: New Therapies vs Stem Cell Transplan…
Apr 3, 2024
targetedonc.com
Case Overview: A 75-Year-Old Man with Multiple Myeloma | Targeted …
Apr 7, 2021
targetedonc.com
Mechanism of Action: Abraxane | Targeted Oncology - Immunothera…
Feb 5, 2014
targetedonc.com
Case Presentation: Diffuse Large B-cell Lymphoma | Targeted Oncolo…
May 3, 2021
targetedonc.com
Belumosudil Shows Sustained Efficacy and Safety for Chronic G…
Mar 11, 2024
targetedonc.com
Nirogacestat Shows Statistically Significant Improvements in Desm…
Nov 28, 2023
targetedonc.com
A Case of Uncontrolled Polycythemia Vera | Targeted Onc…
May 12, 2022
targetedonc.com
BrECADD Shows Promise as New Standard for Advanced Hodgkin L…
Jun 1, 2024
targetedonc.com
The Differences Between mCRPC and nmCRPC | Targeted Oncolog…
Jul 17, 2019
targetedonc.com
3:38
Updates from PAPILLON: 1L Amivantamab Chemotherapy in A…
Nov 14, 2023
targetedonc.com
DLBCL: Frontline Therapy for GCB and ABC Subtypes | Targeted Onc…
Oct 29, 2021
targetedonc.com
FDA's July 2024 Roundup: Breakthroughs and Milestones in …
Aug 2, 2024
targetedonc.com
See more videos
Static thumbnail place holder